The Hindu Business Line : Ranbaxy signs pact with Canadian co

Ranbaxy Pharmaceuticals Canada Inc said on Friday that it signed a second licensing and supply agreement with Canada-based pharma company Janssen-Ortho Inc. The wholly-owned subsidiary of Ranbaxy Laboratories Ltd will market and sell the generic Fentanyl patch, under the label RAN Fentanyl Transdermal System.

Classified as an opioid analgesic drug, the drug is prescribed for moderate to severe chronic pain management. The Canadian market is the eighth largest in the world for the drug. The company expects the market for a generic Fentanyl patch to reach CAD 50 Million.

Ranbaxy, which started operations in Canada in September 2005, licensed the first generic in the country in July. That time too it partnered with Janssen-Ortho Inc psychotic disorder drug Risperidone that sells under the Ranbaxy label.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Reliance bags Hyderabad airport fuel farm operations

`Escorts-acquisition benefits in three years'

ABB plans robot manufacturing centre in India

Cipla sets up Dubai subsidiary

Sona Group to invest $10 m in N. America

Ranbaxy signs pact with Canadian co

`Reliance Industries Q2 profit may grow by 6 per cent'

`Leyland's FY07 sales target to rise by 4-5 pc'

Lakshmi Mills forays into readymade garments segment

Equity being raised for three projects: Orient Paper

P&G's new units to commence production this quarter

Essar awaits Mehsana block results

JSW Steel registers 7 pc increase in pellet production